What is the current price of IHL.AX stock?

As of this intraday update on 05 Mar 2026, IHL.AX stock trades at **A$0.041**, down **10.87%** from the prior close, with volume near **61,360,016** shares.

What drives IHL.AX stock price movements?

Price moves are driven by clinical trial progress, news coverage, and low liquidity. Incannex’s pipeline milestones and headline risk frequently trigger large intraday volume and price swings.

What is Meyka AI’s forecast for IHL.AX stock?

Meyka AI's forecast model projects **A$0.095** within 12 months versus the current **A$0.041**, implying about **131.71%** upside. Forecasts are model-based projections and not guarantees.

How does Meyka grade IHL.AX stock?

Meyka AI rates IHL.AX **65.07 out of 100 (Grade B)** with a **HOLD** suggestion. The grade balances sector benchmarks, financial growth, metrics and limited analyst coverage.

AU Stocks

IHL.AX stock -10.87% intraday on ASX 05 Mar 2026: watch volume surge

ByHuzaifa Zahoor March 5, 2026

The most active ASX ticker today is IHL.AX stock, trading at A$0.041 as of this intraday update on 05 Mar 2026. Volume has surged to 61,360,016 shares, nearly ten times the average, driving a -10.87% move from yesterday’s close of A$0.046. Traders are reacting to thin market depth, a long-term low of A$0.041, and continued clinical-program newsflow in the healthcare sector. This piece examines trading activity, fundamentals, technicals, and price forecasts for Incannex Healthcare Limited on the ASX.